
Hepatitis B Vaccine Study Halted in Africa Amid Ethical Concerns
A US-funded study in Guinea-Bissau investigating hepatitis B vaccines in newborns has been cancelled due to ethical concerns regarding the withholding of proven preventative vaccines in a high-risk population. Experts raised concerns about the study's design, emphasizing the importance of ethical research practices in Africa and the need for evidence-based policies that prioritize public health. This decision underscores the critical role of ethical oversight in medical research to ensure the well-being of vulnerable populations.


















Discussion
Join the conversation
Be the first to comment